Ondine Biomedical says Lantern trial meets primary efficacy endpoint
Ondine Biomedical says its Lantern trial met the primary efficacy endpoint.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.